https://de.marketscreener.com/kurs/aktie/ACTINIUM-PHARMACEUTICALS--16113719/news/Actinium-Pharmaceuticals-Inc-hebt-die-Fahigkeit-von-Iomab-B-hervor-die-Hochrisiko-TP53-Mutation-46471126/?utm_source=telegram&utm_medium=social&utm_campaign=share